Manhattan Scientifics, Inc.
MHTX
$0.0001
$0.000.00%
| Weiss Ratings | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.08 | |||
| Price History | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | -87.50% | |||
| 60-Day Total Return | -87.50% | |||
| 90-Day Total Return | -90.00% | |||
| Year to Date Total Return | -88.89% | |||
| 1-Year Total Return | -97.78% | |||
| 2-Year Total Return | -98.57% | |||
| 3-Year Total Return | -99.19% | |||
| 5-Year Total Return | -99.27% | |||
| 52-Week High % Change | -97.80% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Jan 28, 2025 | |||
| 52-Week High Price (Date) | Mar 12, 2024 | |||
| Valuation | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 55.93K | |||
| Enterprise Value | 1.14M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | 0.00% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -0.02 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.00 | |||
| Enterprise Value/EBITDA (TTM) | -1.66 | |||
| Enterprise Value/EBIT | -1.66 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 559.28M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 541 2405 | |||
| Address | 244 Fifth Avenue New York, NY 10001 | |||
| Website | mhtx.com | |||
| Country | United States | |||
| Year Founded | 1992 | |||
| Profitability | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -132.78% | |||
| Return on Equity | -- | |||
| Income Statement | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -682.60K | |||
| EBIT (TTM) | -683.00K | |||
| Net Income (TTM) | -1.06M | |||
| Net Income Avl. to Common (TTM) | -1.06M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 31.00% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 25.00% | |||
| Balance Sheet | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 38.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 45.00K | |||
| Total Preferred Equity (Q) | 1.06 | |||
| Total Equity (Q) | -2.34M | |||
| Current Ratio (Q) | 0.019 | |||
| Book Value Per Share (Q) | -$0.01 | |||
| Total Assets (Q) | 74.00K | |||
| Total Current Liabilities (Q) | 2.42M | |||
| Total Debt (Q) | 60.00K | |||
| Total Liabilities (Q) | 2.42M | |||
| Total Common Equity (Q) | -3.40M | |||
| Cash Flow | MHTX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 106.00K | |||
| Cash from Financing (TTM) | -10.00K | |||
| Net Change in Cash (TTM) | -14.00K | |||
| Levered Free Cash Flow (TTM) | 146.10K | |||
| Cash from Operations (TTM) | -110.00K | |||
